Paromomycin Sulfate
NDC Package 76413-147-63
Package Information
Paromomycin Sulfate is a medication used to treat a certain parasite infection of the intestines (amebiasis). Marketed by Central Texas Community Health Centers, this product is identified by NDC 76413-147 and is authorized under FDA application ANDA065173.
Identification & Billing
- RxCUI: 314184 - paromomycin sulfate 250 MG Oral Capsule
- RxCUI: 314184 - paromomycin 250 MG Oral Capsule
- RxCUI: 314184 - paromomycin (as paromomycin sulfate) 250 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76413 - Central Texas Community Health Centers
- 76413-147 - Paromomycin Sulfate
- 76413-147-63 - 63 CAPSULE in 1 BOTTLE
- 76413-147 - Paromomycin Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (76413-147). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76413-147-63 identifies a specific commercial package of 63 capsule in 1 bottle of Paromomycin Sulfate, labeled by Central Texas Community Health Centers. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Central Texas Community Health Centers on October 22, 2009. The current certification is valid through December 31, 2019.
What are the primary indications for this medication?
This medication is used to treat a certain parasite infection of the intestines (amebiasis). This medication is known as an aminoglycoside antibiotic. It works by stopping the growth of parasites in the intestines. This medication is poorly absorbed into the blood so it will not work for infections outside of the intestines. Paromomycin may also be used along with a special diet to treat a certain serious brain problem (hepatic encephalopathy). This condition occurs in people with liver disease and is caused by too much of a certain natural substance (ammonia) in the body. Normally the liver gets rid of the ammonia. Paromomycin helps to treat hepatic encephalopathy by stopping the growth of certain bacteria in your intestines that make ammonia. This antibiotic treats only parasitic and bacterial infections. It will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.
How is this Central Texas Community Health Centers product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76413014763. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.